axicabtagene ciloleucel
daiichi sankyo,gilead
['axicabtagene ciloleucel', 'zuma 7', 'dlbcl', 'axi-cel', 'lymphoma', 'lymsm']
great to see more robust prospective data about pet mtv and dlbcl outcomes, especially from zuma 7- feels so much more objective than spd although my nucl. med colleagues tell me it can be time consuming! #lymsm #ash22 #ash2022 
Clinical haematologist at Peter MacCallum Cancer Centre in Melbourne. Aggressive Lymphoma Lead. MDS/AML/myeloma.Early phase trials. Views are my own.